Coronavirus Tarik Jasarevic guidelines medicines patient Coronavirus Tarik Jasarevic

WHO suspends remdesivir from list of medicines after warning against use on hospitalised Covid patients

WHO) on Friday suspended popular antiviral medicine remdesivir from its so-called prequalification list, which is an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised coronavirus patients."Yes we have suspended it from the PQ (prequalification list)," WHO spokesperson Tarik Jasarevic said in an emailed response to news agency Reuters. "The suspension is a signal to countries that WHO, in compliance with the treatment guidelines, does not recommend countries procure the drug for COVID."The report also added that the WHO was not aware that any international procurers were providing the drug to low and middle-income countries.WHO warns against its use.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News